Deep Vein Thrombosis (DVT) News and Research

RSS
USA Vein Clinics to open new center in Marietta, GA

USA Vein Clinics to open new center in Marietta, GA

Jersey Coast Vascular Institute, Meridian Health partner to accept a wide range of insurances

Jersey Coast Vascular Institute, Meridian Health partner to accept a wide range of insurances

Daiichi Sankyo receives FDA approval for SAVAYSA (edoxaban) Tablets

Daiichi Sankyo receives FDA approval for SAVAYSA (edoxaban) Tablets

Daiichi Sankyo releases new formulation of LIXIANA 60 mg Tablets

Daiichi Sankyo releases new formulation of LIXIANA 60 mg Tablets

Stago receives FDA approval for automated, highly sensitive D-dimer test

Stago receives FDA approval for automated, highly sensitive D-dimer test

ESC launches first recommendations on use of all new oral anticoagulants in pulmonary embolism

ESC launches first recommendations on use of all new oral anticoagulants in pulmonary embolism

Study aims at best way to treat deep vein thrombosis

Study aims at best way to treat deep vein thrombosis

European Commission approves Boehringer Ingelheim's Pradaxa for prevention of DVT and PE

European Commission approves Boehringer Ingelheim's Pradaxa for prevention of DVT and PE

Bristol-Myers Squibb, Pfizer announce FDA approval of Eliquis for DVT prophylaxis

Bristol-Myers Squibb, Pfizer announce FDA approval of Eliquis for DVT prophylaxis

Long-term risks of deep vein thrombosis

Long-term risks of deep vein thrombosis

Mobile compression device just as effective as blood thinners in preventing DVT after joint surgery

Mobile compression device just as effective as blood thinners in preventing DVT after joint surgery

Bristol-Myers Squibb fourth quarter 2013 revenues increase 6% to $4.4 billion

Bristol-Myers Squibb fourth quarter 2013 revenues increase 6% to $4.4 billion

Daiichi Sankyo submits Marketing Authorization Application for edoxaban to EMA

Daiichi Sankyo submits Marketing Authorization Application for edoxaban to EMA

Phase III EINSTEIN trial program: XARELTO reduces risk of DVT and PE

Phase III EINSTEIN trial program: XARELTO reduces risk of DVT and PE

August edition of NPS RADAR includes reviews for new medicines listed on PBS

August edition of NPS RADAR includes reviews for new medicines listed on PBS

ACC report helps clinicians optimize appropriate use of noninvasive vascular tests

ACC report helps clinicians optimize appropriate use of noninvasive vascular tests

Bristol-Myers Squibb, Pfizer announce FDA acceptance of Eliquis sNDA for review

Bristol-Myers Squibb, Pfizer announce FDA acceptance of Eliquis sNDA for review

Boehringer submits application to EMA for use of Pradaxa for treatment of acute DVT, PE

Boehringer submits application to EMA for use of Pradaxa for treatment of acute DVT, PE

CLOTS 3 trial demonstrates efficacy of Covidien's Kendall SCD system on immobile stroke patients

CLOTS 3 trial demonstrates efficacy of Covidien's Kendall SCD system on immobile stroke patients

Perosphere, Daiichi Sankyo sign clinical trial agreement

Perosphere, Daiichi Sankyo sign clinical trial agreement

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.